Ultralife Co. (NASDAQ:ULBI – Get Free Report) Director Bradford T. Whitmore purchased 2,140 shares of the stock in a transaction dated Thursday, May 15th. The stock was acquired at an average cost of $5.72 per share, for a total transaction of $12,240.80. Following the transaction, the director now owns 1,048,087 shares of the company’s stock, valued at approximately $5,995,057.64. This trade represents a 0.20% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Ultralife Stock Down 3.2%
ULBI opened at $5.73 on Friday. The company has a fifty day moving average price of $4.92 and a 200-day moving average price of $6.60. The firm has a market capitalization of $95.31 million, a P/E ratio of 10.42 and a beta of 0.77. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.30 and a quick ratio of 1.62. Ultralife Co. has a one year low of $4.07 and a one year high of $12.40.
Ultralife (NASDAQ:ULBI – Get Free Report) last announced its earnings results on Friday, May 9th. The technology company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.02). Ultralife had a return on equity of 7.92% and a net margin of 5.44%. The company had revenue of $50.75 million during the quarter, compared to analysts’ expectations of $54.50 million. During the same quarter last year, the firm posted $0.21 earnings per share.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on ULBI
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently added to or reduced their stakes in ULBI. Jones Financial Companies Lllp lifted its stake in Ultralife by 1,428.7% in the first quarter. Jones Financial Companies Lllp now owns 15,287 shares of the technology company’s stock worth $82,000 after purchasing an additional 14,287 shares during the last quarter. Nuveen LLC purchased a new position in shares of Ultralife during the first quarter valued at about $116,000. IFP Advisors Inc grew its holdings in Ultralife by 24.6% in the first quarter. IFP Advisors Inc now owns 14,200 shares of the technology company’s stock worth $76,000 after purchasing an additional 2,800 shares during the period. Pitti Group Wealth Management LLC grew its holdings in Ultralife by 23.4% in the first quarter. Pitti Group Wealth Management LLC now owns 21,120 shares of the technology company’s stock worth $114,000 after purchasing an additional 4,000 shares during the period. Finally, Visionary Wealth Advisors grew its holdings in Ultralife by 17.1% in the fourth quarter. Visionary Wealth Advisors now owns 1,292,836 shares of the technology company’s stock worth $9,632,000 after purchasing an additional 188,384 shares during the period. 30.68% of the stock is currently owned by hedge funds and other institutional investors.
Ultralife Company Profile
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Read More
- Five stocks we like better than Ultralife
- Using the MarketBeat Dividend Yield Calculator
- Top 4 ETFs for China Exposure After Tariff Relief
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Build a Complete Bond Portfolio With These 4 ETFs
- What is the Dogs of the Dow Strategy? Overview and Examples
- MarketBeat Week in Review – 05/12 – 05/16
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.